Schutt Aj

579 total citations
33 papers, 422 citations indexed

About

Schutt Aj is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Schutt Aj has authored 33 papers receiving a total of 422 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 11 papers in Molecular Biology and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Schutt Aj's work include Colorectal Cancer Treatments and Studies (9 papers), Gastric Cancer Management and Outcomes (6 papers) and Cancer Research and Treatments (4 papers). Schutt Aj is often cited by papers focused on Colorectal Cancer Treatments and Studies (9 papers), Gastric Cancer Management and Outcomes (6 papers) and Cancer Research and Treatments (4 papers). Schutt Aj collaborates with scholars based in United States. Schutt Aj's co-authors include Moertel Cg, Robert G. Hahn, Carney Ja, Martin Jk, Ilstrup Dm, van Heerden Ja, O'Connell Mj, Adson Ma, Stephen Frytak and J. Purvis and has published in prestigious journals such as PubMed and Munich Personal RePEc Archive (Ludwig Maximilian University of Munich).

In The Last Decade

Schutt Aj

32 papers receiving 371 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Schutt Aj United States	11	227	135	105	92	83	33	422
Masao Sekiya Japan	12	102 0.4×	95 0.7×	56 0.5×	100 1.1×	59 0.7×	41	437
D. Mignard France	7	289 1.3×	43 0.3×	83 0.8×	216 2.3×	54 0.7×	10	442
Stephen H. Rosenoff United States	11	141 0.6×	34 0.3×	90 0.9×	78 0.8×	13 0.2×	16	417
O'Connell Mj United States	10	195 0.9×	56 0.4×	44 0.4×	98 1.1×	36 0.4×	34	318
O Almersjö Sweden	14	206 0.9×	110 0.8×	235 2.2×	54 0.6×	14 0.2×	45	558
Chabner Ba United States	10	238 1.0×	24 0.2×	36 0.3×	132 1.4×	52 0.6×	21	483
Jesus M. Matos United States	11	315 1.4×	212 1.6×	250 2.4×	69 0.8×	17 0.2×	21	486
Wittes Re United States	12	215 0.9×	112 0.8×	36 0.3×	87 0.9×	30 0.4×	24	377
Toshiki Kamano Japan	12	259 1.1×	53 0.4×	261 2.5×	93 1.0×	8 0.1×	108	534
G Martz Switzerland	14	336 1.5×	68 0.5×	28 0.3×	93 1.0×	19 0.2×	36	535

Countries citing papers authored by Schutt Aj

Since Specialization

Citations

This map shows the geographic impact of Schutt Aj's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Schutt Aj with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Schutt Aj more than expected).

Fields of papers citing papers by Schutt Aj

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Schutt Aj. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Schutt Aj. The network helps show where Schutt Aj may publish in the future.

Co-authorship network of co-authors of Schutt Aj

This figure shows the co-authorship network connecting the top 25 collaborators of Schutt Aj. A scholar is included among the top collaborators of Schutt Aj based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Schutt Aj. Schutt Aj is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Aj, Schutt, et al.. (1983). Phase II study of ftorafur in previously untreated and treated patients with advanced colorectal cancer.. PubMed. 67(5). 505–6. 3 indexed citations

Aj, Schutt, et al.. (1983). Phase II study of hycanthone in patients with advanced colorectal carcinoma.. PubMed. 67(6). 593–4. 4 indexed citations

Aj, Schutt, et al.. (1982). Phase II study of mitolactol and semustine combination chemotherapy for advanced malignant melanoma.. PubMed. 66(6). 1425–6. 1 indexed citations

Aj, Schutt, et al.. (1982). Phase II study of high-dose megestrol acetate in patients with advanced malignant melanoma.. PubMed. 66(5). 1239–40. 7 indexed citations

Aj, Schutt, et al.. (1982). Phase II study of an aziridinylbenzoquinone (AZQ) in disseminated malignant melanoma.. PubMed. 66(12). 2089–90. 1 indexed citations

Purvis, J., et al.. (1981). Phase II study of PALA in advanced large bowel carcinoma.. PubMed. 65(3-4). 335–6. 9 indexed citations

Cg, Moertel, et al.. (1981). Phase II trial of indicine N-oxide (INDI) in patients with advanced colorectal carcinoma.. PubMed. 65(3-4). 337–9. 7 indexed citations

Mj, O'Connell, et al.. (1980). Lack of clinical therapeutic synergism between cyclophosphamide, adriamycin, and cis-dichlorodiammineplatinum(II) in metastatic human colorectal carcinoma.. PubMed. 64(2-3). 311–3. 4 indexed citations

Mj, O'Connell, Moertel Cg, Schutt Aj, et al.. (1977). Phase II study of cytosine arabinoside in advanced large bowel cancer.. PubMed. 61(9). 1725–6. 2 indexed citations

10.

Cg, Moertel, et al.. (1976). Phase II studies of dianhydrogalactitol and VP-16-213 in colorectal cancer.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 60(9). 1247–50. 20 indexed citations

11.

Cg, Moertel, et al.. (1976). Phase II study of cytembena (NSC-104801) in advanced colorectal carcinoma.. PubMed. 59(3). 581–3. 1 indexed citations

12.

Cg, Moertel, et al.. (1975). Phase II study of chromomycin A3 (NSC-58514) in advanced colorectal carcinoma.. PubMed. 59(3). 577–9. 2 indexed citations

13.

Cg, Moertel, et al.. (1975). Phase II study of ICRF-159 (NSC-129943) in advanced colorectal carcinoma.. PubMed. 59(4). 761–3. 22 indexed citations

14.

Cg, Moertel, et al.. (1974). Treatment of advanced squamous cell carcinoma of the gastrointestinal tract with bleomycin (NSC-125066).. PubMed. 57(4). 493–5. 19 indexed citations

15.

Cg, Moertel, et al.. (1974). Phase I study of chromomycin A (NSC-58514).. PubMed. 57(3). 341–7. 2 indexed citations

16.

Cg, Moertel, et al.. (1974). Phase II study of cis-diamminedichloroplatinum (NSC-119875) in advanced carcinoma of the large bowel.. PubMed. 57(3). 357–9. 42 indexed citations

17.

Cg, Moertel, et al.. (1972). Effect of resection of the primary neoplasm on responsiveness to chemotherapy of patients with large bowel cancer.. PubMed. 56(4). 551–2. 2 indexed citations

18.

Cg, Moertel, et al.. (1972). Phase II study of bleomycin (NSC-125066) therapy for large bowel cancer.. PubMed. 56(2). 207–10. 3 indexed citations

19.

Cg, Moertel, et al.. (1972). Phase II study of 5-azacytidine (NSC-102816) in the treatment of advanced gastrointestinal cancer.. PubMed. 56(5). 649–52. 21 indexed citations

20.

Cg, Moertel, et al.. (1970). 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) in patients with gastrointestinal carcinoma.. PubMed. 54(6). 471–3. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact